Back to Browse Journals » Vascular Health and Risk Management » Volume 5

The management of gestational diabetes

Authors N Wah Cheung

Published Date January 2009 Volume 2009:5 Pages 153—164

DOI http://dx.doi.org/10.2147/VHRM.S3405

Published 15 January 2009

N Wah Cheung

Centre for Diabetes and Endocrinology Research, Westmead Hospital, and University of Sydney, NSW, Australia

Abstract: The incidence of gestational diabetes is increasing. As gestational diabetes is associated with adverse pregnancy outcomes, and has long-term implications for both mother and child, it is important that it is recognized and appropriately managed. This review will examine the pharmacological options for the management of gestational diabetes, as well as the evidence for blood glucose monitoring, dietary and exercise therapy. The medical management of gestational diabetes is still evolving, and recent randomized controlled trials have added considerably to our knowledge in this area. As insulin therapy is effective and safe, it is considered the gold standard of pharmacotherapy for gestational diabetes, against which other treatments have been compared. The current experience is that the short acting insulin analogs lispro and aspart are safe, but there are only limited data to support the use of long acting insulin analogs. There are randomized controlled trials which have demonstrated efficacy of the oral agents glyburide and metformin. Whilst short-term data have not demonstrated adverse effects of glyburide and metformin on the fetus, and they are increasingly being used in pregnancy, there remain long-term concerns regarding their potential for harm.

Keywords: gestational diabetes, insulin, oral antidiabetic agents, pregnancy, type 2 diabetes

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Corrigendum]

Yu L, Wang XL, Zhu D, Ding WC, Wang LM, Zhang CL, Jiang XH, Shen H, Liao SJ, Ma D, Hu Z, Wang H

OncoTargets and Therapy 2015, 8:365-366

Published Date: 4 February 2015

Diagnostic performance of a combination of Mini-Mental State Examination and Clock Drawing Test in detecting Alzheimer’s disease

Kato Y, Narumoto J, Matsuoka T, Okamura A, Koumi H, Kishikawa Y, Terashima S, Fukui K

Neuropsychiatric Disease and Treatment 2013, 9:581-586

Published Date: 30 April 2013

Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis

Hertel N, Kotchie RW, Samyshkin Y, Radford M, Humphreys S, Jameson K

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:183-199

Published Date: 19 March 2012

Survival of prostate cancer patients in central and northern Denmark, 1998–2009

Borre M, Erichsen R, Lund L, Larsen EH, Nørgaard M, Jacobsen JB

Clinical Epidemiology 2011, 3:41-46

Published Date: 21 July 2011

Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India

Krishna K Sharma, Rajeev Gupta, Aachu Agrawal, et al

Vascular Health and Risk Management 2009, 5:1007-1014

Published Date: 20 November 2009

Coenzyme Q10 effects in neurodegenerative disease

Meredith Spindler, M Flint Beal, Claire Henchcliffe

Neuropsychiatric Disease and Treatment 2009, 5:597-610

Published Date: 9 November 2009

Efficacy and safety of rosuvastatin in the management of dyslipidemia

Paolo Rubba, Gennaro Marotta, Marco Gentile

Vascular Health and Risk Management 2009, 5:343-352

Published Date: 7 April 2009

Alveolar dead space and capnographic variables before and after thrombolysis in patients with acute pulmonary embolism

Marcos Mello Moreira, Renato G G Terzi, Carlos Heitor N Carvalho, Antonio Francisco de Oliveira Neto, Mônica Corso Pereira, Ilma Aparecida Paschoal

Vascular Health and Risk Management 2009, 5:9-12

Published Date: 24 November 2008